NCT05047484View on ClinicalTrials.gov

A Study of Multiple Doses of ALXN2050 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

July 23, 2019

Study Completion Date

July 23, 2019

Conditions
Healthy
Interventions
DRUG

ALXN2050

Powder-in-capsule (PIC).

DRUG

Placebo

PIC.

Trial Locations (1)

Unknown

Clinical Trial Site, Auckland

Sponsors
All Listed Sponsors
collaborator

Achillion, a wholly owned subsidiary of Alexion

INDUSTRY

lead

Alexion Pharmaceuticals, Inc.

INDUSTRY